NetworkNewsBreaks – Canopy Rivers Inc.’s (TSX:
Post# of 87
Canopy Rivers’ (TSX: RIV) (OTC: CNPOF) cornerstone investor, Canopy Growth Corporation (TSE: WEED) (NYSE: CGC), was featured in a BNN Bloomberg article by David George-Cosh titled, “Strong medical sales help Canopy Growth beat Q1 estimates.” Among other highlights, the article discusses Canopy Growth Corp.’s recently reported fiscal first-quarter financial results. The article reads, “Canopy, the world’s largest cannabis company by market valuation, said that its medical cannabis business outperformed in its three-month period ending June 30, while also seeing revenue gains from its German pharmaceutical subsidiary and its topical cream products.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer